Insmed
在场
是其中之一......
Insmed 是一家在股票代码 INSM (US) 下上市的公司。
Insmed 在 2 个国家有直接业务。
他们在：
高管
查看带有其 27 名主要高管的组织结构图
Insmed 搜索最多的简介
- Will Lewis, President, Chief Executive Officer and Chairman of the...
- Alfred Altomari, Director
- Melvin Sharoky, Director
创建提醒
跟踪 Insmed 的高管变动
药店
Insmed 拥有 1,830 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Insmed 的最新新闻稿
- News Releases - Insmed
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Insmed Incorporated
- Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities for 2019 | Insmed Incorporated
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Insmed Incorporated
- Insmed Announces Changes to its Board of Directors | Insmed Incorporated
- Insmed to Present at Three November Conferences | Insmed Incorporated
- Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update | Insmed Incorporated
- Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018 | Insmed Incorporated
- Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatment with ARIKAYCE® (amikacin liposome inhalation suspension) | Insmed Incorporated
- Insmed Extends Patent Protection in Japan to 2033 | Insmed Incorporated
- View more press releases Close
通过电子邮件
